Why is Edison focusing on mitochondrial disease?
Edison’s commitment to inherited mitochondrial diseases is based on two reasons. First, there are no treatments for the pernicious, debilitating, and lethal diseases. Secondly, the information derived through developing drugs for inherited mitochondrial diseases are likely to have direct applications to other diseases, such as Huntington’s disease, where defects in mitochondrial function have also been implicated.